Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory S Merrick

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Urologic Nursing|June 28, 2006
Cholesterol, cholesterol lowering agents/statins, and urologic disease: part II--do you know your Framingham Risk Score?Mark A Moyad, Gregory S Merrick
Urologic Nursing|May 15, 2007
Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part VI--The recent rise and fall of the HDL-boosting drug torceptrapibMark A Moyad, Gregory S Merrick
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 8, 2016
Focal prostate brachytherapy with (103)Pd seedsWayne M Butler, Gregory S Merrick
Urologic Oncology|May 12, 2005
Statins and cholesterol lowering after a cancer diagnosis: why not?Mark A Moyad, Gregory S Merrick
Medical Physics|February 24, 2010
Comment on the "AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: Report of Task Group 137" [Med. Phys. 36, 5310-5322 (2009)]Gregory S Merrick, John C Blasko
Oncology (Williston Park, N.Y.)|October 10, 2006
Treatment of prostate cancer in obese patientsHiroki Mitsuyama, Kent E Wallner, Gregory S Merrick
Oncology (Williston Park, N.Y.)|October 7, 2010
Androgen deprivation therapy: a survival benefit or detriment in men with high-risk prostate cancer?L Christine Fang, Gregory S Merrick, Kent E Wallner
Brachytherapy|February 13, 2010
Evaluation of radiobiologic biochemical control in a large permanent prostate brachytherapy population from a single institution using AAPM TG-137 parametersWayne M Butler, Renee R Stewart, Gregory S Merrick
Urology|November 20, 2003
Minimizing prostate brachytherapy-related morbidityGregory S Merrick, Kent E Wallner, Wayne M Butler
The Journal of Urology|April 11, 2003
Permanent interstitial brachytherapy for the management of carcinoma of the prostate glandGregory S Merrick, Kent E Wallner, Wayne M Butler
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Urologic Nursing|June 28, 2006
Cholesterol, cholesterol lowering agents/statins, and urologic disease: part II--do you know your Framingham Risk Score?Mark A Moyad, Gregory S Merrick
Urologic Nursing|May 15, 2007
Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part VI--The recent rise and fall of the HDL-boosting drug torceptrapibMark A Moyad, Gregory S Merrick
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 8, 2016
Focal prostate brachytherapy with (103)Pd seedsWayne M Butler, Gregory S Merrick
Urologic Oncology|May 12, 2005
Statins and cholesterol lowering after a cancer diagnosis: why not?Mark A Moyad, Gregory S Merrick
Medical Physics|February 24, 2010
Comment on the "AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: Report of Task Group 137" [Med. Phys. 36, 5310-5322 (2009)]Gregory S Merrick, John C Blasko
Oncology (Williston Park, N.Y.)|October 10, 2006
Treatment of prostate cancer in obese patientsHiroki Mitsuyama, Kent E Wallner, Gregory S Merrick
Oncology (Williston Park, N.Y.)|October 7, 2010
Androgen deprivation therapy: a survival benefit or detriment in men with high-risk prostate cancer?L Christine Fang, Gregory S Merrick, Kent E Wallner
Brachytherapy|February 13, 2010
Evaluation of radiobiologic biochemical control in a large permanent prostate brachytherapy population from a single institution using AAPM TG-137 parametersWayne M Butler, Renee R Stewart, Gregory S Merrick
Urology|November 20, 2003
Minimizing prostate brachytherapy-related morbidityGregory S Merrick, Kent E Wallner, Wayne M Butler
The Journal of Urology|April 11, 2003
Permanent interstitial brachytherapy for the management of carcinoma of the prostate glandGregory S Merrick, Kent E Wallner, Wayne M Butler
Pageof 19